Ile to Val polymorphism at codon 655 of HER-2 gene and breast cancer risk in Iranian women

Cancer Letters
Eskandar Kamali-SarvestaniAhmad Merat

Abstract

The earlier reports on the association between the Ile to Val polymorphism at codon 655 of HER-2 and susceptibility to breast cancer has not been found to hold true for all ethnic populations. Two hundred and four cases and 138 controls were collected to investigate the association of HER-2 Ile655Val polymorphism with the risk of breast cancer development and progression in Iranian population. This association was not found to be significant in the present study (OR = 1.16, 95% CI: 0.67-2.03). The association between HER-2 genotypes frequency and clinicopathological data was also insignificant, suggesting that the HER-2 polymorphism at codon 655 is unlikely to be a susceptibility locus in Iranian patients with breast cancer.

References

Oct 11, 1991·Nucleic Acids Research·J PapewalisM F Rajewsky
Sep 1, 1988·Molecular and Cellular Biology·D F SternH Cao
Jul 10, 1987·Science·P P Di FioreS A Aaronson
Jan 1, 1994·Breast Cancer Research and Treatment·I SchönbornR Grosse
Nov 3, 1998·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·F RévillionJ P Peyrat
Mar 4, 2000·Journal of the National Cancer Institute·D XieW Zheng
Apr 5, 2001·Journal of the National Cancer Institute·S W Baxter, I G Campbell
Nov 8, 2001·Journal of the National Cancer Institute·S Wang-Gohrke, J Chang-Claude
Oct 17, 2002·Journal of the National Cancer Institute·Kelvin Y K ChanUi-Soon Khoo
Dec 5, 2002·Journal of the National Cancer Institute·Asahi HishidaKazuo Tajima
Jul 9, 2003·Breast Cancer Research and Treatment·Robert MillikanLynn Dressler
Aug 21, 2003·Journal of the National Cancer Institute·Michael HauptmannJeffery P Struewing
Oct 22, 2003·Epidemiology·Joni L RutterJeffrey Struewing

❮ Previous
Next ❯

Citations

Aug 10, 2007·Breast Cancer Research and Treatment·Shimian QuWei Zheng
Apr 29, 2008·Breast Cancer Research and Treatment·Weiyang TaoHongchi Jiang
Apr 20, 2010·Breast Cancer Research and Treatment·Su LuXishan Hao
Aug 30, 2008·DNA and Cell Biology·Hicran MutluhanErtugrul Seyrek
Apr 13, 2010·DNA and Cell Biology·Nurten KaraHasan Bagci
Jul 4, 2008·Pharmacogenomics·Patrick R Benusiglio
Dec 20, 2007·European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)·Pavol ZuborJan Danko
Dec 23, 2009·Clinical Biochemistry·Łukasz KruszynaPaweł P Jagodziński
Jun 27, 2007·The Breast Journal·Seyed Mohsen MousaviMandana Ebrahimi
Oct 8, 2008·Annals of the New York Academy of Sciences·Awatif SiddigAbdu Adem
Dec 19, 2014·Asian Pacific Journal of Cancer Prevention : APJCP·Wei ChenYun-Lin Wei
Jan 6, 2011·Genetic Testing and Molecular Biomarkers·Ezgi SezginBeyhan Demirhan
Nov 26, 2009·Genetic Testing and Molecular Biomarkers·Imen KallelAhmed Rebaï
Mar 11, 2006·Familial Cancer·Gert Matthijs
Apr 30, 2005·Carcinogenesis·Bernd FrankBarbara Burwinkel
May 24, 2006·World Journal of Gastroenterology : WJG·N-Lale Satiroglu-TufanNese Calli-Demirkan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Ductal

Ductal carcinoma is a malignant neoplasm involving the ductal systems of any of a number of organs, such as the mammary glands, pancreas, prostate or lacrimal gland. Discover the latest research on ductal carcinoma here.